Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort study

被引：0
|
作者：
Jia Peng
Ming-Ming Liu
Jing-Lu Jin
Ye-Xuan Cao
Yuan-Lin Guo
Na-Qiong Wu
Cheng-Gang Zhu
Qian Dong
Jing Sun
Rui-Xia Xu
Jian-Jun Li
机构：
[1] Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Cardiovascular Diseases, Fu Wai Hospital, National Center for Cardiovascular Diseases
来源：
Cardiovascular Diabetology | / 19卷
关键词：
PCSK9; DM; CAD; Maces; Cardiovascular metabolic markers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort study
    Peng, Jia
    Liu, Ming-Ming
    Jin, Jing-Lu
    Cao, Ye-Xuan
    Guo, Yuan-Lin
    Wu, Na-Qiong
    Zhu, Cheng-Gang
    Dong, Qian
    Sun, Jing
    Xu, Rui-Xia
    Li, Jian-Jun
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [2] Relation of circulating PCSK9 concentration to fibrinogen in patients with stable coronary artery disease
    Zhang, Yan
    Zhu, Cheng-Gang
    Xu, Rui-Xia
    Li, Sha
    Guo, Yuan-Lin
    Sun, Jing
    Li, Jian-Jun
    JOURNAL OF CLINICAL LIPIDOLOGY, 2014, 8 (05) : 494 - 500
  • [3] The Relationship between Circulating PCSK9 Concentration and Coronary Damage Severity in Patients with Cardiovascular Disease
    Choi, Yeon Kyung
    Bae, Kwi Hyun
    Kim, Mi Jin
    Seo, Jung Beom
    Ham, Hye Jin
    Park, Keun Gyu
    DIABETES, 2017, 66 : A121 - A121
  • [4] NO ASSOCIATION BETWEEN CHANGES IN LIPID PARAMETERS AND TOTAL PCSK9 IN CORONARY ARTERY DISEASE PATIENTS TREATED WITH PCSK9 INHIBITORS
    Ugovsek, S.
    Likozar, A. Rehberger
    Sebestjen, M.
    ATHEROSCLEROSIS, 2023, 379 : S173 - S173
  • [5] Regression of Coronary Atherosclerosis With the PCSK9 Inhibitor Evolocumab in Patients With Coronary Artery Disease and Diabetes
    King, Peta
    Puri, Rishi
    Koenig, Wolgang
    Brennan, Danielle M.
    Somaratne, Ransi
    Kassahun, Helina
    Wasserman, Scott M.
    Nissen, Steven E.
    Nicholls, Stephen J.
    CIRCULATION, 2017, 136
  • [6] Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina
    Caselli, Chiara
    Del Turco, Serena
    Ragusa, Rosetta
    Lorenzoni, Valentina
    De Graaf, Michiel
    Basta, Giuseppina
    Scholte, Arthur
    De Caterina, Raffaele
    Neglia, Danilo
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (01)
  • [7] Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina
    Chiara Caselli
    Serena Del Turco
    Rosetta Ragusa
    Valentina Lorenzoni
    Michiel De Graaf
    Giuseppina Basta
    Arthur Scholte
    Raffaele De Caterina
    Danilo Neglia
    Cardiovascular Diabetology, 18
  • [8] PCSK9 GENETIC VARIANTS IN PATIENTS WITH CORONARY ARTERY DISEASE - A PILOT STUDY
    Ashavaid, T. F.
    Bane, A.
    Ponde, C. K.
    Rajani, R. M.
    Pillai, S.
    ATHEROSCLEROSIS, 2018, 275 : E224 - E225
  • [9] Biochemical markers in patients with coronary artery disease and diabetes mellitus: prospective observational study
    Petelina, T. I.
    Musikhina, N. A.
    Gapon, L. I.
    Kuznetsov, V. A.
    Belosludtseva, O. E.
    CARDIOVASCULAR RESEARCH, 2014, 103
  • [10] Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease
    Rui-Xia Xu
    Sha Li
    Yan Zhang
    Xiao-Lin Li
    Yuan-Lin Guo
    Cheng-Gang Zhu
    Jian-Jun Li
    Lipids in Health and Disease, 13
12345